Results 321 to 330 of about 209,758 (346)

Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.

Contraception, 2013
F. Stanczyk, D. Archer, B. Bhavnani
semanticscholar   +1 more source

Oral contraceptives, combined.

IARC monographs on the evaluation of carcinogenic risks to humans, 1999
openaire   +1 more source

ORAL CONTRACEPTIVES AND OVARIAN CANCER RISK

Ca-A Cancer Journal for Clinicians, 2008
exaly  

Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception

Lancet, The, 1998
exaly  

Combined oral contraceptives in polycystic ovary syndrome - indications and cautions.

Frontiers of Hormone Research, 2013
G. Bozdag, B. Yıldız
semanticscholar   +1 more source

EFFECT OF COMBINED ŒSTROGEN-PROGESTOGEN ORAL CONTRACEPTIVES, ŒSTROGEN, AND PROGESTOGEN ON ANTIPLASMIN AND ANTITHROMBIN ACTIVITY

Lancet, The, 1970
exaly  

Combination oral contraceptives.

Current therapy in endocrinology and metabolism, 1995
openaire   +1 more source

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

Lancet, The, 1999
Saskia Middeldorp, Stella Thomassen, Gerry A F Nicolaes   +2 more
exaly  

Combined oral contraceptives.

Nursing times, 2005
openaire   +1 more source

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

Lancet, The, 2002
Victor Moreno, Sergio Munoz, Chris J L M Meijer   +2 more
exaly